Connect with us

Health

‘Minuscule’ clotting risk after AstraZeneca Covid jabs: India – Macau Business

An analysis of adverse health effects in people who received the AstraZeneca Covid-19 vaccine in India found that the number of blood clot cases

Published

on

An analysis of adverse health effects in people who received the AstraZeneca Covid-19 vaccine in India found that the number of blood clot cases was “minuscule”, the health ministry said Monday.
Some countries have restricted or dropped AstraZeneca shots from national vaccine campaigns over very rare blood clots, though experts have said the benefits outweigh the risks.
The Oxford-AstraZeneca jab — one of three shots granted emergency approval in India — is the most widely used in the country and…

Click here to view the original article.

Continue Reading
Advertisement

You might also like ...

Article feature image
Australia’s Victoria state reports 1 new COVID case – Yahoo News
Article feature image
New radiopharmaceutical shows therapeutic efficacy in preclinical model of ovarian cancer – News-Medical.Net